ABT-751 (E7010)
Selleck Chemicals
SKU:S1165-10MG
Couldn't load pickup availability

ABT-751 (E7010) is an inhibitor linked to Cell Cycle Regulation and related pathway-oriented research. It is especially relevant when investigators need a named chemical input and interpretable readouts connected to checkpoint control, mitotic progression, and proliferation timing in cancer and cell cycle models.
The pathway annotation connects ABT-751 (E7010) to Cell Cycle Regulation, supporting experiments that monitor checkpoint control, mitotic progression, and proliferation timing across biochemical, cellular, or phenotypic assay formats. This context is compatible with cell-cycle, mitotic, and proliferation assays, as well as transcriptional, biochemical, or phenotypic comparisons linked to the annotated pathway state. In cancer and cell cycle models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.
Research Applications
- Pathway perturbation studies connected to Cell Cycle Regulation
- Concentration-response inhibition and target-dependence studies
- Phenotypic profiling in cancer and cell cycle models
- Combination studies with orthogonal perturbagens
Overall, ABT-751 (E7010) is well suited to pathway-oriented studies that need a defined compound input for Cell Cycle Regulation readouts in cancer and cell cycle models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.
- Pathways:
- Cell Cycle Regulation
- Research Area:
- Cancer • Cell Cycle
- CAS No.:
- 141430-65-1
- Molecular Weight:
- 371.41
- Formula:
- C₁₈H₁₇N₃O₄S
- SMILES:
- COC1=CC=C(C=C1)S(=O)(=O)NC2=C(N=CC=C2)NC3=CC=C(C=C3)O
- InChIKey:
- URCVCIZFVQDVPM-UHFFFAOYSA-N
- PubChem:
- 3035714
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.